Cerba European Lab swells high yield pipeline to seven deals in Europe
Cerba European Lab has become the latest speculative grade company to announce high yield bond plans today (Monday). The French operator of clinical pathology laboratories in Europe raises the tally of deals being marketed in Europe to seven, worth some €3.9bn equivalent, in euros, dollars and sterling.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts